China detains South Korean on suspicion of espionage (updated)
Brief: Astellas Pharma Inc - Update On Marketing Authorization Application For Avacincaptad Pegol (Acp) In The European Union
Brief: Astellas's Vyloy Currently Available At Wholesale Acquisition Cost Of $1600.00 Per 100MG Vial- Spokesperson
FDA approves Astellas' gastric cancer therapy (updated)
FDA approves Astellas' gastric cancer therapy
Brief: FDA Approves Astellas' Vyloy For A Type Of Gastroesophageal Junction Adenocarcinoma
Brief: Japan's Astellas To Close Biopharmaceutical Manufacturing Facility In California This Fiscal Year, Nikkei Says
Brief: FDA Adds Warning About Rare Occurrence Of Serious Liver Injury With Use Of Veozah (Fezolinetant) For Hot Flashes Due To Menopause
Japanese citizen indicted on suspicion of espionage, China confirms (updated)
China confirms Japanese citizen indicted on suspicion of espionage
Brief: Astellas Pharma Spokesperson: Employee Detained In China Has Been Indicted By Chinese Authorities
Japanese Astellas employee indicted by China prosecutors, Kyodo reports (updated)
Japanese Astellas employee indicted by China prosecutors, Kyodo reports
Brief: China's National Medical Products Administration (Nmpa) Approves PADCEV (Enfortumab Vedotin) For Treatment Of Locally Advanced Or Metastatic Urothelial Cancer
Brief: Astellas Pharma Inc: China's National Medical Products Administration Approves PADCEV For Treatment Of Locally Advanced Or Metastatic Urothelial Cancer
Astellas' gastric cancer therapy gets UK regulator's nod (updated)
UK regulator approves Astellas' gastric cancer drug
Brief: UK's MHRA Approves Zolbetuximab To Treat Adults With Stomach Or Gastro-Oesophageal Junction Cancer
Table: Astellas -Q1 group results (IFRS)